Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Inhibition of human prion neuropeptide PrP106-126 aggregation by hexacoordinated ruthenium complexes.

Wang X, Zhang B, Zhao C, Wang Y, He L, Cui M, Zhu X, Du W.

J Inorg Biochem. 2013 Nov;128:1-10. doi: 10.1016/j.jinorgbio.2013.07.009. Epub 2013 Jul 15.

PMID:
23911565
2.

Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.

Wang X, Zhu D, Zhao C, He L, Du W.

Metallomics. 2015 May;7(5):837-46. doi: 10.1039/c5mt00029g. Epub 2015 Apr 9.

PMID:
25856332
3.

Gold complexes inhibit the aggregation of prion neuropeptides.

Wang X, He L, Zhao C, Du W, Lin J.

J Biol Inorg Chem. 2013 Oct;18(7):767-78. doi: 10.1007/s00775-013-1030-4. Epub 2013 Aug 28.

PMID:
23982344
4.

Palladium complexes affect the aggregation of human prion protein PrP106-126.

Wang Y, Feng L, Zhang B, Wang X, Huang C, Li Y, Du W.

Inorg Chem. 2011 May 16;50(10):4340-8. doi: 10.1021/ic102331x. Epub 2011 Apr 19.

PMID:
21504185
5.

Influence of gold-bipyridyl derivants on aggregation and disaggregation of the prion neuropeptide PrP106-126.

Zhao C, Wang X, He L, Zhu D, Wang B, Du W.

Metallomics. 2014 Nov;6(11):2117-25. doi: 10.1039/c4mt00219a.

PMID:
25273168
6.

Regulation of aggregation behavior and neurotoxicity of prion neuropeptides by platinum complexes.

Wang X, Cui M, Zhao C, He L, Zhu D, Wang B, Du W.

Inorg Chem. 2014 May 19;53(10):5044-54. doi: 10.1021/ic500092t. Epub 2014 May 2.

PMID:
24787240
7.

Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.

Salmona M, Malesani P, De Gioia L, Gorla S, Bruschi M, Molinari A, Della Vedova F, Pedrotti B, Marrari MA, Awan T, Bugiani O, Forloni G, Tagliavini F.

Biochem J. 1999 Aug 15;342 ( Pt 1):207-14.

8.

PrP106-126 peptide disrupts lipid membranes: influence of C-terminal amidation.

Zheng W, Wang L, Hong Y, Sha Y.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):298-303. doi: 10.1016/j.bbrc.2008.12.049. Epub 2008 Dec 25.

PMID:
19103159
9.

Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.

Jobling MF, Huang X, Stewart LR, Barnham KJ, Curtain C, Volitakis I, Perugini M, White AR, Cherny RA, Masters CL, Barrow CJ, Collins SJ, Bush AI, Cappai R.

Biochemistry. 2001 Jul 10;40(27):8073-84.

PMID:
11434776
10.

Prion peptide 106-126 as a model for prion replication and neurotoxicity.

Singh N, Gu Y, Bose S, Kalepu S, Mishra RS, Verghese S.

Front Biosci. 2002 Apr 1;7:a60-71.

PMID:
11897566
11.

PrP106-126 amide causes the semi-penetrated poration in the supported lipid bilayers.

Zhong J, Zheng W, Huang L, Hong Y, Wang L, Qiu Y, Sha Y.

Biochim Biophys Acta. 2007 Jun;1768(6):1420-9. Epub 2007 Mar 19.

12.

Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.

Kawahara M, Koyama H, Nagata T, Sadakane Y.

Metallomics. 2011 Jul;3(7):726-34. doi: 10.1039/c1mt00015b. Epub 2011 Mar 28.

PMID:
21442127
13.

Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126.

Kanapathipillai M, Ku SH, Girigoswami K, Park CB.

Biochem Biophys Res Commun. 2008 Jan 25;365(4):808-13. Epub 2007 Nov 26.

PMID:
18039468
14.

Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.

Liu YH, Han YL, Song J, Wang Y, Jing YY, Shi Q, Tian C, Wang ZY, Li CP, Han J, Dong XP.

Int J Biochem Cell Biol. 2011 May;43(5):768-74. doi: 10.1016/j.biocel.2011.01.022. Epub 2011 Feb 3.

PMID:
21296677
15.

Copper(II) interaction with unstructured prion domain outside the octarepeat region: speciation, stability, and binding details of copper(II) complexes with PrP106-126 peptides.

Di Natale G, Grasso G, Impellizzeri G, La Mendola D, Micera G, Mihala N, Nagy Z, Osz K, Pappalardo G, Rigó V, Rizzarelli E, Sanna D, Sóvágó I.

Inorg Chem. 2005 Oct 3;44(20):7214-25.

PMID:
16180886
16.

Cellular uptake of the prion protein fragment PrP106-126 in vitro.

McHattie SJ, Brown DR, Bird MM.

J Neurocytol. 1999 Feb;28(2):149-59.

PMID:
10590514
17.
18.

Copper binding to the neurotoxic peptide PrP106-126: thermodynamic and structural studies.

Belosi B, Gaggelli E, Guerrini R, Kozłowski H, Łuczkowski M, Mancini FM, Remelli M, Valensin D, Valensin G.

Chembiochem. 2004 Mar 5;5(3):349-59.

PMID:
14997527
19.

Synthetic miniprion PrP106.

Bonetto V, Massignan T, Chiesa R, Morbin M, Mazzoleni G, Diomede L, Angeretti N, Colombo L, Forloni G, Tagliavini F, Salmona M.

J Biol Chem. 2002 Aug 30;277(35):31327-34. Epub 2002 Jun 10.

20.

Methionine oxidation of amyloid peptides by peroxovanadium complexes: inhibition of fibril formation through a distinct mechanism.

He L, Wang X, Zhu D, Zhao C, Du W.

Metallomics. 2015 Dec;7(12):1562-72. doi: 10.1039/c5mt00133a. Epub 2015 Oct 7.

PMID:
26444976

Supplemental Content

Support Center